ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$179.84

Market cap

$82.06B

P/E Ratio

34.65

Dividend/share

$1.67

EPS

$5.19

Enterprise value

$86.86B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
Zoetis's EPS has increased by 17% YoY and by 2.2% QoQ
The net income has grown by 15% YoY and by 2% from the previous quarter
Zoetis's quick ratio has decreased by 3.4% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: PFE LLY MRK ICCC

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
456.3M
Market cap
$82.06B
Enterprise value
$86.86B
Valuations
Price to earnings (P/E)
34.65
Price to book (P/B)
16.28
Price to sales (P/S)
9.43
EV/EBIT
26.95
EV/EBITDA
23.35
EV/Sales
9.94
Earnings
Revenue
$8.73B
EBIT
$3.22B
EBITDA
$3.72B
Free cash flow
$1.75B
Per share
EPS
$5.19
Free cash flow per share
$3.83
Book value per share
$11.05
Revenue per share
$19.07
TBVPS
$22.48
Balance sheet
Total assets
$14.35B
Total liabilities
$9.3B
Debt
$6.77B
Equity
$5.06B
Working capital
$4.45B
Liquidity
Debt to equity
1.34
Current ratio
3.33
Quick ratio
1.71
Net debt/EBITDA
1.29
Margins
EBITDA margin
42.6%
Gross margin
70%
Net margin
27.4%
Operating margin
36.9%
Efficiency
Return on assets
16.9%
Return on equity
48.4%
Return on invested capital
24.5%
Return on capital employed
25.9%
Return on sales
36.9%
Dividend
Dividend yield
0.93%
DPS
$1.67
Payout ratio
32.2%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-0.51%
1 week
0.71%
1 month
5.23%
1 year
-6.33%
YTD
-8.88%
QTD
3.74%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8.73B
Gross profit
$6.12B
Operating income
$3.22B
Net income
$2.39B
Gross margin
70%
Net margin
27.4%
The net income has grown by 15% YoY and by 2% from the previous quarter
Zoetis's operating income has increased by 13% YoY
The gross profit has grown by 9% YoY and by 2.3% from the previous quarter
ZTS's revenue is up by 8% YoY and by 2.2% QoQ

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
ZTS P/E details
P/E
34.65
P/B
16.28
P/S
9.43
EV/EBIT
26.95
EV/EBITDA
23.35
EV/Sales
9.94
Zoetis's EPS has increased by 17% YoY and by 2.2% QoQ
The P/E is 15% lower than the 5-year quarterly average of 40.8 and 2.9% lower than the last 4 quarters average of 35.7
The stock's price to book (P/B) is 15% less than its 5-year quarterly average of 19.2
ZTS's equity is up by 13% year-on-year
ZTS's price to sales (P/S) is 10% lower than its 5-year quarterly average of 10.5 and 2.8% lower than its last 4 quarters average of 9.7
ZTS's revenue is up by 8% YoY and by 2.2% QoQ

Efficiency

How efficient is Zoetis business performance
ZTS's return on assets is up by 14% year-on-year
The company's return on equity rose by 6% YoY
Zoetis's return on sales has increased by 4.5% YoY

Dividends

What is ZTS's dividend history
Dividend details
DPS
$1.67
Dividend yield
0.93%
Payout ratio
32.2%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 54% greater than its total liabilities
ZTS's total assets is up by 4.3% year-on-year
Zoetis's quick ratio has decreased by 3.4% QoQ
The debt is 34% higher than the equity
ZTS's equity is up by 13% year-on-year
Zoetis's debt to equity has decreased by 11% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.